UTICA, N.Y., Sept. 21 /PRNewswire-FirstCall/ -- CONMED Corporation
(Nasdaq: CNMD), a medical technology organization specializing in a wide range
of medical devices for surgical and patient monitoring markets, announced
today that the Company will make a presentation to investors at the UBS Life
Sciences Conference on Monday, September 26, 2005 at 3:30 PM Eastern time.
The event will be held in New York City at the Grand Hyatt Hotel.
Mr. Joseph J. Corasanti, President and Chief Operating Officer of CONMED,
will discuss the Company's business. The live webcast of CONMED's
presentation will be available at http://www.conmed.com in the Investor
Relations - Events Calendar section of the website and will be available for
replay through October 4, 2005.
CONMED Profile
CONMED is a medical technology company with an emphasis on surgical
devices and equipment for minimally invasive procedures and patient
monitoring. The Company's products serve the clinical areas of sports
medicine-arthroscopy, powered surgical instruments, electrosurgery, cardiac
monitoring disposables, endosurgery and endoscopic technologies. Surgeons and
physicians in a variety of specialties including orthopedics, general surgery,
gynecology, neurosurgery, and gastroenterology use the Company's medical
devices. Headquartered in Utica, New York, the Company's 2,900 employees
distribute its products worldwide from eleven manufacturing locations.
SOURCE CONMED Corporation
 back to top
Related links:
http://www.conmed.com
CONTACT:
Robert Shallish, Chief Financial Officer of
CONMED Corporation, +1-315-624-3206; or Investors - Julie Huang
or Theresa Kelleher, or Media - Sean Leous, all of Financial
Dynamics, +1-212-850-5600, for CONMED
|
